0 likes | 2 Views
The global Herpes Simplex Virus (HSV) Treatment Market was valued at USD 3.1 billion in 2024 and is expected to reach USD 6.9 billion by 2037, growing at a CAGR of 7.2%. This growth is fueled by increased healthcare spending, heightened awareness, and a demand for effective antiviral treatments.
E N D